Safety and enhanced immunogenicity of a hepatitis B core particle Plasmodium falciparum malaria vaccine formulated in adjuvant Montanide ISA 720 in a phase I trial (Q42754531)

From Wikidata
Jump to navigation Jump to search
scientific article published on June 2005
edit
Language Label Description Also known as
English
Safety and enhanced immunogenicity of a hepatitis B core particle Plasmodium falciparum malaria vaccine formulated in adjuvant Montanide ISA 720 in a phase I trial
scientific article published on June 2005

    Statements

    Safety and enhanced immunogenicity of a hepatitis B core particle Plasmodium falciparum malaria vaccine formulated in adjuvant Montanide ISA 720 in a phase I trial (English)
    1 reference
    Giane A Oliveira
    1 reference
    Kristiane Wetzel
    1 reference
    J Mauricio Calvo-Calle
    1 reference
    Annette Schmidt
    1 reference
    Ashley Birkett
    1 reference
    Filip Dubovsky
    1 reference
    Eveline Tierney
    1 reference
    Christoph H Gleiter
    1 reference
    Gabriele Boehmer
    1 reference
    Adrian J F Luty
    1 reference
    Elizabeth H Nardin
    1 reference
    1 June 2005
    1 reference
    73
    1 reference
    3587-3597
    1 reference

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit